Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Helen Of Troy
HELE
Concentration Risk %
Concentration Risk % at other companies
Gyre Therapeutics, Inc.
GYRE
93.1%
-5.3pp
Heartland Express
HTLD
32%
+6.0pp
Enovix Corporation
ENVX
83%
+36.0pp
Weis Markets
WMK
100%
0.0pp
Innoviva, Inc.
INVA
36%
+7.0pp
Strattec Security
STRT
0.5%
0.0pp
Segments
By geography
See full
EMEA
16.4%
+5.8%
Asia Pacific
6%
-9.1%
Latin America
1.9%
-24.0%
By product
See full
Trademark License and Royalty Agreements
32%
—
Other financials
Income statement
See full
Revenue
$470.0M
-3.3%
Gross profit
$209.7M
-11.1%
Operating income
-$51.0M
-2,629%
Net income
-$55.6M
-209%
EPS (diluted)
-$2.38
-207%
Balance sheet
See full
Cash & equivalents
$18.9M
+0.1%
Total debt
$840.7M
-12.7%
Total equity
$798.2M
-52.6%
Total assets
$2.1B
-32.5%
Cash flow
See full
Operating cash flow
$111.3M
+218%
CapEx
$8.2M
+3.8%
Free cash flow
$103.1M
+281%
Valuation
See full
Market cap
$648.22M
+5.7%
Enterprise value
$1.47B
-2.2%
P/S
0.4×
0.0×
Profitability
See full
Gross margin
45.7%
-2.3pp
Operating margin
-43.8%
-51.3pp
Net margin
-50.3%
-56.8pp
FCF margin
6%
-3.1pp
Returns & leverage
See full
Return on equity
-72.5%
-79.9pp
Debt / equity
1.1×
+0.5×
Current ratio
1.7×
-0.3×